For the quarter ending 2026-03-31, CMPX has $205,170K in assets. $18,697K in debts. $55,168K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 55,168 | 30,643 | 46,212 | 22,856 |
| Marketable securities | 139,519 | 178,263 | 173,683 | 78,093 |
| Prepaid expenses and other current assets | 1,000 | 913 | 1,225 | 5,246 |
| Total current assets | 195,687 | 209,819 | 221,120 | 106,195 |
| Total property and equipmentat cost | 6,821 | 6,739 | 6,739 | - |
| Less accumulated depreciation | 6,652 | 6,637 | 6,620 | - |
| Property and equipment, net | 169 | 102 | 119 | 131 |
| Operating lease, right-of-use ('rou') asset | 8,746 | 9,099 | 9,452 | 9,804 |
| Restricted cash | 568 | 568 | 568 | 568 |
| Total assets | 205,170 | 219,588 | 231,259 | 116,698 |
| Accounts payable | 906 | 1,585 | 3,095 | 2,595 |
| Accrued expenses | 8,000 | 11,383 | 8,684 | 10,992 |
| Operating lease obligations, current portion | 1,373 | 1,000 | 633 | 271 |
| Total current liabilities | 10,279 | 13,968 | 12,412 | 13,858 |
| Operating lease obligations, long-term portion | 8,418 | 8,829 | 9,234 | 9,633 |
| Total liabilities | 18,697 | 22,797 | 21,646 | 23,491 |
| Common stock, 0.0001 par value 300,000 shares authorized 180,088 and 178,324 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 18 | 18 | 53 | 14 |
| Additional paid-in-capital | 636,103 | 627,665 | 624,742 | 494,182 |
| Accumulated other comprehensive income (loss) | -159 | 280 | 274 | 208 |
| Accumulated deficit | -449,489 | -431,172 | -415,456 | -401,197 |
| Total stockholders' equity | 186,473 | 196,791 | 209,613 | 93,207 |
| Total liabilities and stockholders' equity | 205,170 | 219,588 | 231,259 | 116,698 |
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)